Abstract:Exploring the molecular mechanisms of breast cancer is essential for the early prediction, diagnosis, and treatment of cancer patients. The large scale of data obtained from the high-throughput sequencing technology makes it difficult to identify the driver mutations and a minimal optimal set of genes that are critical to the classification of cancer. In this study, we propose a novel method without any prior information to identify mutated genes associated with breast cancer. For the somatic mutation data, it is processed to a mutated matrix, from which the mutation frequency of each gene can be obtained. By setting a reasonable threshold for the mutation frequency, a mutated gene set is filtered from the mutated matrix. For the gene expression data, it is used to generate the gene expression matrix, while the mutated gene set is mapped onto the matrix to construct a co-expression profile. In the stage of feature selection, we propose a staged feature selection algorithm, using fold change, false discovery rate to select differentially expressed genes, mutual information to remove the irrelevant and redundant features, and the embedded method based on gradient boosting decision tree with Bayesian optimization to obtain an optimal model. In the stage of evaluation, we propose a weighted metric to modify the traditional accuracy to solve the sample imbalance problem. We apply the proposed method to The Cancer Genome Atlas breast cancer data and identify a mutated gene set, among which the implicated genes are oncogenes or tumor suppressors previously reported to be associated with carcinogenesis. As a comparison with the integrative network, we also perform the optimal model on the individual gene expression and the gold standard PMA50. The results show that the integrative network outperforms the gene expression and PMA50 in the average of most metrics, which indicate the effectiveness of our proposed method by integrating multiple data sources, and can discover the associated mutated genes in breast cancer.

Tumor Informative Genes Selection Based on BP Neural Networks

Informative Gene Selection for Cancer Subtype Classification with BP Neural Networks

Analysis of Gene Sensitivity for Tumor Informative Genes Selection Based on SVM

Study of Informative Gene Selection for Tissue Classification Based on Tumor Gene Expression Profiles

Tumor Diagnosis System Based on Information Entropy and Artificial Neural Networks

A Feature Selection Method for Colon Tumor Based on Gene Expression Profiles

Cancer Informative Gene Identification Based on Statistical Method

Informative gene selection for colon tumor based on similar contribution method and SVM-RFE method

Tumor classification by combining PNN classifier ensemble with neighborhood rough set based gene reduction

Feature (gene) Selection in Gene Expression-Based Tumor Classification

A Hybrid Feature Selection Algorithm and Its Application in Bioinformatics

Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.

Gene Selection and Cancer Classification Using A Fuzzy Neural Network

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

Method for Extracting the Tumor Gene Based on the Support Vector Machine

Method for Gene Selection Based on BQPSO

Towards key genes identification for breast cancer survival risk with neural network models

PLS-Based Gene Selection and Identification of Tumor-Specific Genes

Selection of Feature Genes in Cancer Clsssification

Gene Selection Utilizing Support Vector Machine Methods Based On Sensitivity

A Novel Method for Gene Selection and Cancer Classification